Categorías
-
Adhesives
6
Amines
115
Amino Acids
207
Analytical Reagents
750
Antibiotics
270
Bioactive Small Molecules
798
Aroma Chemicals
242
Biochemicals
1142
Boronic Acids
4
Buffers
104
Building Blocks
2162
Carbohydrates
191
Catalysts
117
Chiral Compounds
78
Coccus nucifera oil
0
Detergents
62
Diagnostic Raw Materials
271
Flavours and Fragrance Materials
234
Fluorinated Products
67
Furans
7
Gases in Solution
51
Grignard Reagents
31
HPLC Reagents
8
Imidazoles
18
Indoles
48
Inorganic Chemicals
357
Ion-Pair Reagents
23
Ligands
81
Organics
1628
Oxazoles
3
Peptide Reagents
99
Phenols
55
Picolines
0
Piperazines
13
Pyrazines
3
Pyridines
65
Pyrimidines
36
Quaternary Ammonium salts
45
Reagents
114
Research Organics & Inorganics
885
Salts
308
Sealing Compounds
1
Sherclin
1
Solvents
132
Stains & Indicators
322
Sugars
66
Tailor-made solutions
1
Testing Standards
4
Uncategorised
22
Water Analysis
13
Actinomycin D
(32117981 | 50-76-0)
CAS: | 50-76-0 |
---|---|
Fórmula molecular: | C62H86N12O16 |
Peso molecular: | 1255.42 |
Disponibilidad: | En stock |
---|---|
Descargas: | | |
Este producto está sujeto a un recargo peligroso. La cantidad exacta será confirmada por nuestro equipo de ventas.
32117981-2mg | 2mg | £59.80 | |
32117981-5mg | 5mg | £73.50 | |
32117981-25mg | 25mg | £159.90 | |
Pedido bulk |
32117981-2mg | 2mg | €83.80 | |
32117981-5mg | 5mg | €102.90 | |
32117981-25mg | 25mg | €223.90 | |
Pedido bulk |
32117981-2mg | 2mg | $89.70 | |
32117981-5mg | 5mg | $110.30 | |
32117981-25mg | 25mg | $239.90 | |
Pedido bulk |
Ficha de datos de seguridad
Especificaciones
Detalle del producto
Product Code | 32117981 | ||||
Product Name | Actinomycin D | ||||
Categories | Antibiotics Bioactive Small Molecules | ||||
CAS | 50-76-0 | ||||
Molecular Formula | C62H86N12O16 | ||||
Molecular Weight | 1255.42 | ||||
Storage Details | 2 to 8 °C | ||||
Harmonised Tariff Code | 29419000 |
Especificaciones del producto
Appearance | Orange red powder |
Información de seguridad
Pictograms |
|
||||
Signal word | danger | ||||
Hazard statements |
|
||||
Precautionary statements |
|